The online version of this article (https://doi.org/10.1186/s12885-018-4543-y) contains supplementary material, which is available to authorized users.
Obesity is found to increase the risk of most cancer types, but reduce lung cancer risk in many studies. However, the association between obesity and lung cancer is still controversial, mainly owing to the confounding effect of smoking.
Eligible studies were identified from electric databases to July 1, 2017. Relevant data were extracted and pooled using random-effects models; dose-response and subgroup analyses were also performed.
Twenty-nine studies with more than 10,000 lung cancer cases in15 million never smokers were included. Compared with normal weight, the summary relative risk (RR) was 0.77(95% confidence interval [CI]: 0.68–0.88, P < 0.01) for excess body weight (body mass index [BMI] ≥ 25 kg/m2). An inverse linear dose-response relationship was observed between BMI and lung cancer risk in never smokers, with an RR of 0.89(95% CI: 0.84–0.95, P < 0.01) per 5 kg/m2 increment in BMI. The results remained stable in most subgroup analyses. However, when stratified by sex, a significant inverse association existed in women but not in men. Similar results were found in analyses for other categories of BMI.
Our results indicate that higher BMI is associated with lower lung cancer risk in never smokers.
Additional file 1: Table S1. Characteristics of studies included in the meta-analysis of obesity and lung cancer risk in non-smokers. (DOCX 88 kb)12885_2018_4543_MOESM1_ESM.docx
Additional file 2: Table S2. Quality scores of the cohort studies included in the meta-analysis, assessed by the Newcastle-Ottawa scale. (DOCX 20 kb)12885_2018_4543_MOESM2_ESM.docx
Additional file 3: Table S3. Quality scores of the case-control studies included in the meta-analysis, assessed by the Newcastle-Ottawa scale. (DOCX 18 kb)12885_2018_4543_MOESM3_ESM.docx
Shen N, Fu P, Cui B, Bu C-Y, Bi J-W. Associations between body mass index and the risk of mortality from lung cancer: a dose–response PRISMA-compliant meta-analysis of prospective cohort studies. Med. 2017;96(34):e7721. CrossRef
Gláucia F. Cota, Marcos R. de Sousa, Tatiani Oliveira Fereguetti, Ana Rabello. Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison. PLOS Negl Trop Dis. 2013;7(5):e2195.
Orsini NBR, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2009;6(1):17.
Xiang Y, Gao Y, Zhong L, Jin F, Sun L, Cheng J, Zhai Y. A case-control study on relationship between body mass index and lung cancer in non-smoking women. Zhonghua Yu Fang Yi Xue Za Zhi. 1999;33(1):9–12. PubMed
Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, et al. Body mass index and cancer incidence:a prospective cohort study in northern China. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35(3):231–6. PubMed
Radoi L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Tarnaud C, Menvielle G, Schmaus A, Cenee S, Carton M, et al. Body mass index, body mass change, and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study. Cancer Causes Control. 2013;24(7):1437–48. CrossRefPubMed
- Body mass index and lung cancer risk in never smokers: a meta-analysis
- BioMed Central
Neu im Fachgebiet Onkologie
e.Med Kampagnen-Visual, Mail Icon II